AbbVie's stock gains on fourth-quarter earnings as it reports better-than-expected sales of HumanaMarket Watch • 02/02/22
AbbVie Showcases Its Leadership in Research in Inflammatory Bowel Diseases with New Analyses to be Presented at the 17th Congress of European Crohn's and Colitis Organization (ECCO)PRNewsWire • 02/01/22
5 High-Yield Dividend Stocks That Can Save Your Portfolio During a Stock Market CrashThe Motley Fool • 02/01/22
Inventiva receives a €4 million milestone payment from AbbVie for cedirogant Phase IIb initiationGlobeNewsWire • 01/31/22